Cannabis Watch: Cannabis stocks rally anew as $7 billion GW Pharma deal spurs interest in weed and its medical benefits
Cannabis stocks rallied anew on Wednesday, spurred on by news of a $7 billion deal for the first company to win U.S. regulatory approval for a cannabis-based drug, a move that's expected to boost investor interest in the plant and its medical benefits.

from MarketWatch.com - Top Stories https://ift.tt/39HC5R5
via IFTTT
from MarketWatch.com - Top Stories https://ift.tt/39HC5R5
via IFTTT
Kommentare
Kommentar veröffentlichen